Investigating how a specific protein affects insulin release in diabetes
Official title: ArpC3-mediated actin remodeling in insulin granule exocytosis and diabetes
Funded at Medical College of Wisconsin · NIH-11001943 · Data updated 2026-11-12
This study is looking at how a protein called ArpC3 affects insulin release from the cells that produce it in people with type-2 diabetes, with the hope of finding new ways to help improve insulin function and treat the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project start | January 1, 2023 |
| Project end | December 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $351,000 |
| NIH project number | 5R01DK132088-03 |
| Project ID | NIH-11001943 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with type-2 diabetes who are over 21 years old.
✕Less likely to help
Patients with type-1 diabetes or those under 21 years old may not receive benefit from this research.
What this research studies
This research focuses on understanding the role of ArpC3, a protein involved in the remodeling of actin filaments, in the process of insulin secretion from beta cells in individuals with type-2 diabetes. By examining how changes in the structure of actin influence insulin release, the study aims to uncover new therapeutic targets that could help restore normal insulin function. The approach includes advanced imaging techniques and functional assays to observe the behavior of beta cells and their signaling pathways. If successful, this research could lead to innovative treatments for diabetes by improving insulin secretion.
Why it matters
Potential benefit: If successful, this research could provide new strategies to enhance insulin secretion in patients with type-2 diabetes.
How similar studies have gone: Previous research has shown promising results in understanding the role of actin remodeling in insulin secretion, indicating that this approach has potential for success.
Where this research is happening
-
Medical College of Wisconsin
Milwaukee, United States Active
Researchers
- Principal investigator: Lou, Xuelin — Medical College of Wisconsin
- Study coordinator: Lou, Xuelin
Related research
Other NIH-funded projects on the same topics.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Retinal signals in early diabetes and how they affect vision
This grant looks at how diabetes changes the signals in the retina that control vision, with a focus on inner retinal cells and how these changes may lead to vision problems.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
Bringing WHO HEARTS-D diabetes care into Bangladesh cities
A program to help urban clinics in Bangladesh adopt WHO HEARTS-D guidelines to improve detection, treatment, and control of type 2 diabetes.
-
AI-powered fundus imaging to screen for type 2 diabetes
A mobile AI tool uses eye images to help screen adults for type 2 diabetes in clinics or communities.
-
AI-powered eye imaging to screen for type 2 diabetes with a mobile phone
A plan to use AI on smartphone retinal images to help spot type 2 diabetes early, especially in people who may not have easy access to care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.